Medications
GSK candidate vaccine helps prevent active pulmonary tuberculosis in HIV negative adults in phase II study
09/26/2018
London 25 September 2018 — Today, GSK and Aeras reported that GSK’s M72/AS01E[1] candidate vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults with latent
Read More
